Processing

Please wait...

Settings

Settings

1. CA2210622 - AN AGENT PROTECTING ENDOTHELIAL CELLS

Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters
CLAIMS
1. An agent for protecting endothelial cells comprising as an effective ingredient interferon.
2. An agent for protective endothelial cells comprising as an effective ingredient interferon according to claim 1, wherein the agent for protecting endothelial cells is a wound healing agent or a preventive/curative agent for a vascular disorder in a cardiovascular disease, a diabetic vascular disorder or a collagen disease.
3. An agent for protecting endothelial cells comprising as an effective ingredient interferon according to claim 1, wherein the agent for protecting endothelial cells is an angiitis curative agent.
4. An agent for protecting endothelial cells comprising as an effective ingredient interferon according to claim 2, wherein the vascular disorder is an ischemic vascular injury or blood flow insufficiency after myocardial infarction or brain vascular infarction, an arteriosclerotic vascular disorder, arteriosclerotic intima hyperplasia and blood flow insufficiency, peripheral arterial imperforation, vascular restenosis after percutaneous vascular dilatation (PTCA), or hypertensive vascular lesion formation.
5. An agent for protecting endothelial cells comprising as an effective ingredient interferon according to claim 2, wherein the diabetic vascular disorder is a great vessel disorder, nephropathy, retinopathy.
6. An agent for protecting endothelial cells comprising as an effective ingredient interferon according to claim 2, wherein the wound healing agent is a curative agent for burn, bedsore, racoma, cutting, wound after operation, chronic skin ulcer, stomatitis chronic skin ulcer in a cancer patient subjected to chemotherapy, angiitis observed in a transplant.
7. An agent for protecting endothelial cells comprising as an effective ingredient interferon according to claim 1, wherein the interferon is α type or β type.
8. An agent for protecting endothelial cells comprising as an effective ingredient interferon according to claim 1, wherein the interferon is β type.
9. An agent for protecting endothelial cells comprising as an effective ingredient interferon according to claim 1, wherein the interferon is a natural interferon- β type.
10. A composition for protecting endothelial cells, containing an effective amount of interferon in a carrier that is pharmacologically allowable.
11. A method for protecting endothelial cells, comprising administering an effective amount of interferon to a patient who needs protection of endothelial cells.